Global Calcium Private Limited — FDA Compliance Timeline

FDA action counts

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Global Calcium Private Limited has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-02-03, Argus HQ recorded an FDA Form 483 inspection citation for Global Calcium Private Limited, rated "high" severity in Argus HQ's classification: Global Calcium Private Limited -- FDA 483: 5 observations (2026-02-03). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

How many FDA actions has Global Calcium Private Limited had?

Argus HQ has recorded 1 FDA events for Global Calcium Private Limited: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Global Calcium Private Limited?

The most recent FDA event Argus HQ has on file for Global Calcium Private Limited is dated 2026-02-03, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Global Calcium Private Limited automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Global Calcium Private Limited is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Global Calcium Private Limited?

1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

Related enforcement actions

• Global Calcium Private Limited -- FDA 483: 5 observations (2026-02-03) →

Compare with

• Global Calcium Private Limited vs Philips North America
• Global Calcium Private Limited vs Medline Industries, LP
• Global Calcium Private Limited vs Boston Scientific Corporation
• Global Calcium Private Limited vs Baxter Healthcare Corporation
• Global Calcium Private Limited vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.